Gene · 1300
Papers2,140
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,140
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Type X collagen knockdown inactivate ITGB1/PI3K/AKT to suppress chronic unpredictable mild stress-stimulated triple-negative breast cancer progression. | Int J Biol Macromol | 2024 | 38866293 | PubTator, text mining | PubMed |
| Upregulation of collagen type X alpha 1 promotes the progress of triple-negative breast cancer via Wnt/β-catenin signaling. | Mol Carcinog | 2024 | 38780151 | PubTator, text mining | PubMed |
| Collagen type X expression and chondrocyte hypertrophic differentiation during OA and OS development. | Am J Cancer Res | 2024 | 38726262 | PubTator, text mining | PubMed |
| Shared biomarkers and mechanisms in idiopathic pulmonary fibrosis and non-small cell lung cancer. | Int Immunopharmacol | 2024 | 38703565 | PubTator, text mining | PubMed |
| Osteoporosis GWAS-implicated DNM3 locus contextually regulates osteoblastic and chondrogenic fate of mesenchymal stem/progenitor cells through oscillating miR-199a-5p levels. | JBMR Plus | 2024 | 38686038 | PubTator, text mining | PubMed |
| Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells. | Front Immunol | 2024 | 38638443 | PubTator, text mining | PubMed |
| Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma. | Front Pharmacol | 2024 | 38572434 | PubTator, text mining | PubMed |
| Bioprinting of gelatin-based materials for orthopedic application. | Front Bioeng Biotechnol | 2024 | 38544981 | PubTator, text mining | PubMed |
| Genetic evaluation using next-generation sequencing of children with short stature: a single tertiary-center experience. | Ann Pediatr Endocrinol Metab | 2024 | 38461804 | PubTator, text mining | PubMed |
| Exploratory genetic analysis in children with autism spectrum disorder and other developmental disorders using whole exome sequencing. | Biomol Biomed | 2024 | 38421723 | PubTator, text mining | PubMed |
| Basement membrane extract potentiates the endochondral ossification phenotype of bone marrow-derived mesenchymal stem cell-based cartilage organoids. | Biochem Biophys Res Commun | 2024 | 38330731 | PubTator, text mining | PubMed |
| Early insights into the role of Exoc6B associated with spondyloepimetaphyseal dysplasia with joint laxity type 3 in primary ciliogenesis and chondrogenic differentiation in vitro. | Mol Biol Rep | 2024 | 38305850 | PubTator, text mining | PubMed |
| The Role of SOX2 and SOX9 in Radioresistance and Tumor Recurrence. | Cancers (Basel) | 2024 | 38275880 | PubTator, text mining | PubMed |
| A single-cell atlas of conventional central chondrosarcoma reveals the role of endoplasmic reticulum stress in malignant transformation. | Commun Biol | 2024 | 38267611 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression. | Int J Mol Sci | 2024 | 38256011 | PubTator, text mining | PubMed |
Involvement of Yes-Associated Protein 1 Activation in the Matrix Degradation of Human-Induced-Pluripotent-Stem-Cell-Derived Chondrocytes Induced by T-2 Toxin and Deoxynivalenol Alone and in Combination. | Int J Mol Sci | 2024 | 38255951 | PubTator, text mining | PubMed |
| Molecular Biology of Meniscal Healing: A Narrative Review. | Int J Mol Sci | 2024 | 38255841 | PubTator, text mining | PubMed |
| Grade 2, 3 and Dedifferentiated Chondrosarcomas: A Comparative Study of Isocitrate Dehydrogenase-Mutant and Wild-Type Tumors with Implications for Prognosis and Therapy. | Cancers (Basel) | 2024 | 38254737 | PubTator, text mining | PubMed |
| PRADclass: Hybrid Gleason Grade-Informed Computational Strategy Identifies Consensus Biomarker Features Predictive of Aggressive Prostate Adenocarcinoma. | Technol Cancer Res Treat | 2024 | 38226611 | PubTator, text mining | PubMed |
| A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3. | NPJ Precis Oncol | 2024 | 38225404 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1300/papers?page=8